MarketPeel
Insider Trading Intelligence
RP

Ryan Preblick

INDV
CHIEF FINANCIAL OFFICER · INDIVIOR PHARMACEUTICALS, INC. · CIK 0002014866
FILING MIX · LIFETIME44%/56%
BUYS
4
SELLS
5
TOTAL VALUE
$4.25M
COMPANIES
1
ACTIVE SINCE
Feb 2026
HOLDINGS NOW
284,751
AVG SELL PX
$33.59
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Ryan Preblick. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
INDV · 284,751 shares · as of Jun 8, 2026
080,899161,797242,696323,594SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 4 buys / 5 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
INDV
INDIVIOR PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
36,000$37.70$1.36M284,751Jun 8, 2026Jun 10, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
6,3020Mar 14, 2026Mar 17, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
6,302323,594Mar 14, 2026Mar 17, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
2,843$31.11$88.4K320,751Mar 14, 2026Mar 17, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
87,597$31.98$2.80M230,343Mar 3, 2026Mar 5, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
PURCHASE
Chief Financial Officer
86,949317,292Mar 3, 2026Mar 5, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
SALE
Chief Financial Officer
113,5100Mar 3, 2026Mar 5, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
37,358317,940Feb 10, 2026Feb 12, 2026View →
INDV
INDIVIOR PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
113,510113,510Feb 9, 2026Feb 12, 2026View →
Other insiders · INDV
Loading peer insiders…
About this filer
CIK 0002014866
ROLE
Chief Financial Officer
PRIMARY
INDV
COMPANIES
1
ACTIVE SINCE
Feb 2026
MARKETPEEL · /INSIDER/0002014866DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback